Flow cytometry showed simvastatin reactivated IFN-γ+ and GZMB+ CD8+ T cells in METTL3-overexpressing NAFLD-HCC allografts (Figure S6E). This evidence concerns the gene IFNG and hepatocellular carcinoma.